Extensive Therapeutic Drug Monitoring of Colistin in Critically Ill Patients Reveals Undetected Risks

(1) Background: With the rise of multi-/pan-drug resistant (MDR/PDR) pathogens, the less utilized antibiotic Colistin has made a comeback. Colistin fell out of favor due to its small therapeutic range and high potential for toxicity. Today, it is used again as a last resort substance in treating MDR...

Descripción completa

Detalles Bibliográficos
Autores principales: Ehrentraut, Stefan Felix, Muenster, Stefan, Kreyer, Stefan, Theuerkauf, Nils Ulrich, Bode, Christian, Steinhagen, Folkert, Ehrentraut, Heidi, Schewe, Jens-Christian, Weber, Matthias, Putensen, Christian, Muders, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143967/
https://www.ncbi.nlm.nih.gov/pubmed/32183443
http://dx.doi.org/10.3390/microorganisms8030415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143967/
https://www.ncbi.nlm.nih.gov/pubmed/32183443
http://dx.doi.org/10.3390/microorganisms8030415

Ejemplares similares